<DOC>
	<DOCNO>NCT00587145</DOCNO>
	<brief_summary>This study open-label , single center , single arm phase II study evaluate clinical response safety perioperative S-1 plus docetaxel . Perioperative chemotherapy compose 3 cycle preoperative S-1/docetaxel 3 cycle postoperative S-1/docetaxel.Chemotherapy regimen : - S-1 80 mg/m2/day every 12-h p.o . day 1 ( even ) -15 ( morning ) - Docetaxel 35 mg/m2 mixed d5w 250 ml iv 60-min day 1 8</brief_summary>
	<brief_title>Phase II Study Perioperative S-1 Plus Docetaxel Patients With Localized Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>1 . Histologically cytologically confirm localized gastric adenocarcinoma define CT stage III IV ( M0 ) ( N3 , metastatic node WHO TNM classification ) , accord Japanese TNM classification system 2 . No distant metastatic disease laparoscopy 3 . Age : 1870 year 4 . Eastern Cooperative Oncology Group ( ECOG ) performance status 01 5 . Disease status must measurable disease define RECIST : Measurable lesion : lesion accurately measure least one dimension abdominal CT , long diameter record least 10 mm spiral CT 6 . Adequate major organ function include follow : Hematopoietic function : WBC ³ 4,000/mm3 , ANC ³ 1,500/mm3 , Platelet ³ 100,000/mm3Hepatic function : serum bilirubin £ 1.5 mg/dl , AST/ALT level £ 2.5 x UNLRenal function : serum creatinine £ 1.5 mg/dl 7 . Patients sign write informed consent study entry 1 . CT Stage I , II , M1 N3 , metastatic node WHO TNM classification , accord Japanese TNM classification system 2 . Prior chemotherapy radiotherapy 3 . Inadequate cardiovascular function : New York Heart Association class III IV heart diseaseUnstable angina myocardial infarction within past 6 monthsHistory significant ventricular arrhythmia require medication antiarrhythmic significant conduction system abnormality 4 . Serious concurrent infection nonmalignant illness uncontrolled whose control may jeopardize complication study therapy 5 . Other malignancy within past 3 year except nonmelanomatous skin cancer carcinoma situ cervix 6 . Psychiatric disorder would preclude compliance 7 . Pregnant , nursing woman patient reproductive potential without contraception 8 . Patients receive concomitant treatment drug interact S1 flucytosine , phenytoin , warfarin et al .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Stomach Neoplasms</keyword>
	<keyword>Secondary</keyword>
	<keyword>Combination chemotherapy</keyword>
	<keyword>S-1</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>oxaliplatin</keyword>
</DOC>